Home>Products>Antibody engineering

Antibody engineering

In recent years, therapeutic antibody drugs have become one of the fastest growing fields in the biopharmaceutical industry. With the development of technology, various forms of engineered antibodies have been constructed to improve their performance, including affinity maturation, Fc engineering, humanization, bispecific or multi-specific antibodies (CrossMab, BiTE, etc.), chimeric antigen receptors (CAR), etc.

Product targets

Humanized monoclonal antibodies
  • bi-specific antibody molecule

Free trial available! Click to apply!

By using the DimAb® antibody development platform and in combination with the predictive bioinformatic analysis, DIMA Biotechnology can provide services for therapeutic antibody drug development, including rabbit antibody humanization, CAR and bispecific antibody molecule construction, etc.


AddressWuhan institute of Biotechnology B7, Biolake No.666 Gaoxin Road, Wuhan, Hubei, China



Follow Us On